Owen N. Witte, Director at Allogene Therapeutics, Inc. (ALLO), bought 52,432 shares at $18.00 ($270K) on 2018-10-15, disclosed to the SEC on 2018-10-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 37,432 | $0 | 0.0% |
| 2 | $18.00 | 15,000 | $270K | 100.0% |
| Total | $5.15 avg | 52,432 | $270K | 100% |
| Filing → |
| ALLO | SELL | 2021-09-09 | $128K | — | Filing → |
| ALLO | SELL | 2021-08-23 | $351K | — | Filing → |
| ALLO | SELL | 2021-06-11 | $499K | — | Filing → |